Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

SPRB Spruce Biosciences Inc

0,4203

0,0009 (0,21%)

04 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
sprb-ars-10k-2022.pdf

Spruce Biosciences (NASDAQ:SPRB)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Spruce Biosciences Charts.

Spruce Biosciences (NASDAQ:SPRB)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Spruce Biosciences Charts.

News Spruce Biosciences, Inc.

Form 8-K - Current report
Freitag 27 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 21 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 21 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 10 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH
Dienstag 10 Dezember 2024 (4 Wochen vor) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 12 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Montag 11 November 2024 (2 Monate vor) • Business Wire

Form 8-K - Current report
Montag 28 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference
Montag 28 Oktober 2024 (2 Monate vor) • Business Wire

Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Dienstag 3 September 2024 (4 Monate vor) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 12 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere Spruce Biosciences, Inc. News-Artikel

Deutsche Lufthansa

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen